Janssen Loses Fight To Keep Remicade Patent In Force
A Massachusetts federal judge on Wednesday invalidated Janssen Biotech Inc.'s patent for the drug Remicade, handing a significant but not decisive victory to Celltrion Healthcare Co. Ltd. and Hospira Inc., which...To view the full article, register now.
Already a subscriber? Click here to view full article